Biktarvy
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Biktarvy in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Biktarvy.
5
Global Revenue Ranking
9
2030 Global forecast Ranking
Recent articles on PMLiVE featuring Biktarvy
An estimated 1.2 million people in the US are currently living with the virus
The phase 4 trial has been comparing Dovato against Gilead’s three-drug regimen, Biktarvy
After changing to Biktarvy, 98% of patients in two groups were suppressed at week 48
The data was shared at the 30th International Congress on Drug Therapy in HIV Infection
The results were presented at the 24th International AIDS Conference
The company has had a ‘very strong’ third quarter in spite of a sharp decline in its HIV portfolio due to generic competition
Total product sales excluding Veklury dropped by 11% to $4.9bn compared to Q1 2020
Turns priority to future growth drivers and R&D investment
Blow to company as it hopes to capture market share from Gilead
Taking aim at rival Biktarvy
Rivals Gilead’s Biktarvy
Comes as Yescarta misses analyst expectations
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology